Axactor (ACR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Gross revenue increased 2% year-over-year to EUR 86.1 million, but declined 3% when adjusted for a EUR 4 million portfolio sale in Spain; total income fell 15% to EUR 54.9 million due to higher NPL amortization and negative revaluations.
Cash EBITDA rose 6% year-over-year to EUR 59 million, supported by cost reductions and the Spanish portfolio sale.
EBITDA was EUR 27 million (margin 48%), down from EUR 34 million last year, including EUR 0.8 million restructuring costs in Italy.
Net profit after tax was EUR 0.6 million, down from EUR 6.1 million, with annualized ROE to shareholders at 0%, reflecting ongoing macroeconomic and funding challenges.
NPL investments for the quarter were EUR 12.6 million, bringing year-to-date investments to EUR 94 million.
Financial highlights
Total income at group level was EUR 54.9 million in Q3, down from EUR 64 million in Q3 2023, impacted by negative revaluations and higher amortization.
Cash EBITDA reached EUR 59 million, up 6% year-over-year, supported by lower operating expenses and the Spanish portfolio sale.
EBITDA margin stood at 48% due to strict cost control.
Operating expenses decreased by 5% year-over-year, with an OpEx ratio of 33%.
Net profit after tax: EUR 0.6 million (vs. EUR 6.1 million y/y); EPS: EUR 0.001 (vs. EUR 0.020 y/y).
Outlook and guidance
Challenging collection environment expected throughout 2024 and into 2025, with inflation and interest rates impacting performance.
Cost inflation anticipated to be absorbed through ongoing OpEx reductions and efficiency initiatives.
Investment target for 2024 remains up to EUR 150 million, with EUR 94 million invested year-to-date.
Modest reduction in funding costs expected in the short to mid-term.
Compliance with all financial covenants as of end Q3, but limited headroom on leverage and interest coverage ratios.
Latest events from Axactor
- Major equity and bond deals cut funding costs and set new growth targets amid revenue decline.ACR
Q1 202629 May 2026 - EUR 200m placement and co-investment deal to drive growth, boost capacity, and reduce leverage.ACR
Investor update29 Apr 2026 - Revenue and margins improved, with strong 3PC growth and focus on deleveraging over dividends.ACR
Q4 202513 Apr 2026 - Cash EBITDA up 3% to EUR 61.1M as cost control offsets 2% revenue decline.ACR
Q2 20241 Feb 2026 - Q4 revenue surged on a Spanish sale, but negative revaluations led to a net loss; liquidity is strong.ACR
Q4 202423 Dec 2025 - Record 12% ROE, 50% EBITDA margin, and 28% 3PC growth highlight strong Q1 results.ACR
Q1 202525 Nov 2025 - Refinancing, strong collections, and 3PC growth support a positive outlook.ACR
Q2 202523 Nov 2025 - Double-digit growth, 53% EBITDA margin, and strong 3PC/NPL performance drive positive outlook.ACR
Q3 202530 Oct 2025 - Spanish portfolio sales and bond buybacks boost Axactor's financial flexibility.ACR
Investor Presentation6 Jun 2025